Cart
sales@molnova.com
P300/CBP-IN-3
CAS No. 2299226-01-8
P300/CBP-IN-3( —— )
Catalog No. M22063 CAS No. 2299226-01-8
P300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 215 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 561 | In Stock |
|
| 50MG | 793 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2186 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameP300/CBP-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionP300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
DescriptionP300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorhistone acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2299226-01-8
-
Formula Weight431.53
-
Molecular FormulaC24H29N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (579.33 mM; Need ultrasonic)
-
SMILESCCN(CC)C1=CC=C(C=N1)C1=NC2=CC(=CC=C2N1CC1=NN(CC)C=C1)C(=O)NC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Apelin-12 (human, bo...
Apelin-12 is one of the most potent C-terminal fragments of the polypeptide that possesses a high affinity to orphan receptor APJ receptor. Apelin-12 is involved in the regulation of body fluid homeostasis and in the central control of feeding. Apelin-12 blocks HIV-1 entry through APJ receptor. Apelin-12 exerts neuroprotective effect.
-
Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
-
ZED-1227
ZED-1227 (TAK-227) is an orally active, selective and potent transglutaminase 2 (TG2) inhibitor with anticancer activity that blocks inflammation-induced TG2 expression and activation for the treatment of Celiac Disease.
